NASDAQ:EVFM

Evofem Biosciences Stock News

etoro logo Buy EVFM
*Your capital is at risk
$0.0080
+0.0015 (+23.08%)
At Close: Jun 03, 2026

July Penny Stocks Buying Guide, 3 Things to Know

11:30am, Saturday, 02'nd Jul 2022
What you need to know about trading penny stocks this month The post July Penny Stocks Buying Guide, 3 Things to Know appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.c

Penny Stocks to Watch as June Comes to an End

08:00pm, Thursday, 30'th Jun 2022
Are these penny stocks on your watchlist right now? The post Penny Stocks to Watch as June Comes to an End appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Evofem Biosciences has already announced a strategic partnership. Here's why this new deal is great news for EVFM stock.
Evofem Biosciences is in the spotlight following the overturning of Roe v. Wade. Here's why EVFM stock is a name to watch.
Shares of Evofem Biosciences Inc. EVFM, +155.45% soared 164.6% in trading on Monday in a rally that began Friday when the Supreme Court decision striking down Roe v. Wade was announced.
Penny stocks to watch with news The post Penny Stocks To Watch: Why EVFM, AGRX, CYBN, HILS & AFIB Stock Are Moving appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Here's what you need to know about trading penny stocks on June 27th The post What to Know About Buying Penny Stocks on June 27th appeared first on Penny Stocks to Buy, Picks, News and Information | P
Shares of Evofem Biosciences Inc. EVFM, +26.95% soared 30.6% in trading on Friday, hours after the Supreme Court decision striking down Roe v. Wade was announced.
Evofem Biosciences Inc (NASDAQ: EVFM) shares are trading lower by 59.76% at $0.44 after the company announced the pricing of a roughly $26.6 million public offering. Evofem says the company intends to
Evofem Biosciences, Inc. (NASDAQ:EVFM ) Q1 2022 Results Conference Call May 4, 2022 4:30 PM ET Company Participants Amy Raskopf - Vice President-Investor Relations Saundra Pelletier - Chief Executive
SAN DIEGO , April 26, 2022 /PRNewswire/ -- Evofem Biosciences, Inc., (Nasdaq: EVFM) today announced it will present new data from the Phase 3 AMPOWER Clinical Trial at the 2022 American College of
Evofem Biosciences, Inc. (NASDAQ:EVFM) with the stream of -2.05% also noticed, India Eloxx Pharmaceuticals, Inc. (NASDAQ:ELOX) encountered a rapid change of 12.90% in the last hour of Thursday’s trading session. … The post Stock on fire: Evofem Biosciences, Inc. (NASDAQ:EVFM), Eloxx Pharmaceuticals, Inc. (NASDAQ:ELOX) appeared first on Stocks Equity .
Shares of Evofem Biosciences (EVFM) are down 5% after the companys Q4 2021 results missed on the bottom line.
Evofem Biosciences press release (EVFM): Q4 GAAP EPS of -$0.33 misses by $0.10.Revenue of $3.57M (+2000.0% Y/Y) beats by $0.21M.Reduced net cash burn rate to $16.8 million in the…
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE